Consortium at a glance
A multilateral initiative to foster the clinical development of effective malaria vaccine candidates in Africa.
MIMVaC-Africa consortium is a large interdisciplinary consortium formed by malaria vaccine developpers from academia, industry and NGO, plus clinical trial experts.
The consortium constitutes in total of ten (10) partner institutions from the world, resolutely committed to the fight against malaria through the development of malaria vaccines. The MIMVaC-Africa officially started its activities on 31 March 2020 and is coordinated by the Groupe de Rechechre Action en Santé (GRAS) based in Burkina Faso.
Workpackages
MIMVaC-Africa is organized into seven (07) work packages which implement the activities.
About Us
The MIMVaC-Africa consortium is a large interdisciplinary consortium formed by leading vaccine developpers, clinical trial experts and malaria researchers.
Governance
The MIMVaC-Africa governance is multi-layered comprising the General assembly (GA), the Project Steering Committee (PSC) and an External Independent Scientific Advisory Group (EISAG).
Latest News
Thanks for taking a little times to follow our news through these articles.
MIMVaC-Africa 2nd annual meeting : on face-to-face in Tübingen
MIMVaC-Africa 2nd annual meeting : on face-to-face in Tübingen MIMVaC-Africa consortium held its 2nd annual meeting on January 17th – 18th, 2023. Thanks to the recent decrease in COVID-19 restrictions, this meeting was possible on [...]
Start of the BLOOMy study in GABON
Start of the BLOOMy study in GABON In the framework of the MIMVaC-Africa consortium, a baseline malaria epidemiology study (BLOOMy) was to be conducted in the future phase 2b malaria vaccine trial sites in Burkina, [...]
World Malaria Day 2022 : MIMVaC-Africa takes to the field for an effective vaccine
World Malaria Day 2022 : MIMVaC-Africa takes to the field for an effective vaccine World Malaria Day is commemorated every April 25 throughout the world. This commemoration allows the different actors to take stock of [...]
“ None of us, acting alone, can achieve the success. ”
Partners
The consortium includes many of the foremost research groups in this field:
- Europe: Eberhard Karls Universität Tübingen (EKUT), Germany; The Chancellor, the Masters and the Scholars of the University of Oxford (UOXF), UK; European Vaccine Initiative (EVI), Germany; Leiden University Medical Center (LUMC), the Netherlands; and Luxembourg Institute of Health (LIH), Luxembourg;
- Asia: Osaka University, Japan.
- Africa : Groupe de Recherche Action en Santé (GRAS), Burkina Faso ; Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon ; Fundação Manhiça, Mozambique ; Ifakara Health Institute (IHI), Tanzania.
